Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inovio Pharma (NQ: INO )

4.060 +0.090 (+2.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharma

< Previous 1 2 3 4 5 6 7 8 9 Next >
Novavax Working On New COVID-19 Vaccine To Combat Omicron Variant
Novavax Inc (NASDAQ: NVAX) said it had started working on a version of its COVID-19 vaccine to target the variant detected in South Africa. It said that the shot would be... 
Via Benzinga
Exposures COVID-19
Battle of the COVID Vaccine Contenders: Inovio vs. Ocugen
Both vaccine makers still have big hurdles to jump. 
Via The Motley Fool
Exposures COVID-19
Does This News Make Inovio Pharmaceuticals Stock a Buy?
The company is closer than ever to launching its coronavirus vaccine -- but will it be good enough to make the stock worth purchasing? 
Via The Motley Fool
Exposures COVID-19
Why Inovio Stock Is Rising Today
The company received a green light to begin a U.S. phase 3 study of its COVID-19 vaccine candidate. 
Via The Motley Fool
Exposures COVID-19 Product Safety
Inovio Pharmaceuticals (INO) Q3 2021 Earnings Call Transcript
INO earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Inovio Pharmaceuticals Sees A Bounce Off Support After COVID-19 Vaccine News
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Tuesday after the FDA removed a hold on the company’s late-stage COVID-19 vaccine trial in the U.S.... 
Via Benzinga
Exposures COVID-19 Product Safety
Why Shares of Inovio Pharmaceuticals Rallied Today
The FDA lifted its hold on the next step of its COVID-19 vaccine trial, although that doesn't mean much at this point. 
Via The Motley Fool
Exposures COVID-19 Product Safety
RBLX Stock Alert: What Is Going on With Roblox Shares Today?
Roblox (RBLX) stock is soaring higher on Tuesday following the release of the company's earnings report for the third quarter of 2021. 
Via InvestorPlace
INO Stock: The Covid-19 Vaccine News Helping Inovio Power Higher
Inovio Pharmaceuticals (INO) stock is pushing higher on Tuesday after providing investors with an update on its Covid-19 vaccine. 
Via InvestorPlace
Exposures COVID-19
FDA Lifts Clinical Hold On Inovio's COVID-19 Vaccine Trial
The FDA has lifted a partial clinical hold on a late-stage trial of Inovio Pharmaceuticals Inc's (NASDAQ: INO) COVID-19 vaccine in the U.S. Inovio said it... 
Via Benzinga
Exposures COVID-19 Product Safety
Rising Test Accuracy Standards Needed as On-Site Demand for Covid-19 Testing Increases
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – After the launch of US President Joe Biden’s pushing of mandatory vaccination/testing in the... 
Via FinancialNewsMedia
Exposures COVID-19
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the... 
Via Benzinga
AstraZeneca's Medimmune Terminates DNA Cancer Vaccine Program With Inovio
MedImmune Limited, a unit of AstraZeneca Plc (NASDAQ: AZN), has notified Inovio Pharmaceuticals Inc (NASDAQ: INO) to terminate the DNA cancer vaccine... 
Via Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage
Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral... 
Via Talk Markets
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
Via Benzinga
Is This The Turning Point for Inovio?
The biotech's streak of bad luck may be about to end, but risks remain. 
Via The Motley Fool
Exposures COVID-19
Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine
Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing... 
Via FinancialNewsMedia
Exposures COVID-19
New Covid-19 Vaccines Continue to Be Developed by Biotech Firms Seeking to Improve the Jab
FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 6, 2021 – USA News Group – As vaccine passport programs continue to roll out in new markets across the globe, especially in... 
Via FinancialNewsMedia
Exposures COVID-19
Is Vaccine Latecomer Inovio Making a Comeback?
Its new plan for phase 3 trials is advancing. 
Via The Motley Fool
Exposures COVID-19
As the Virus Continues, the Global Covid-19 Vaccine Market Expected to Reach $25 Billion By 2024
Via FinancialNewsMedia
Exposures COVID-19
Looking Into Inovio Pharmaceuticals's Return On Capital Employed
Inovio Pharmaceuticals (NASDAQ:INO) brought in sales totaling $272.82 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 58.32%, resulting... 
Via Benzinga
Etsy And NetApp Lead The S&P 500
U.S. indices were trading lower Thursday as traders await signs of Fed tapering policy. Explosions outside of Kabul airport in Afghanistan has also caused macro uncertainty and... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Inovio Stock Is Jumping Today
The vaccine maker received some good news from Brazil. 
Via The Motley Fool
Exposures COVID-19
Inovio Pharmaceuticals Stock Nears End Of Technical Pattern
Inovio Pharmaceuticals Inc. (NASDAQ:INO) shares are trading... 
Via Benzinga
Inovio To Start Global Late-Stage COVID-19 Vaccine Trial
The regulatory authority of Brazil has signed off Inovio Pharmaceuticals Inc's (NASDAQ: INO) global Phase 3 segment of its INNOVATE Phase 2/3 trial for INO-... 
Via Benzinga
Exposures COVID-19
Why Inovio's Stock Is Trading Higher Today
Inovio Pharmaceuticals Inc (NASDAQ: INO) is trading higher Thursday after the company announced it received regulatory authorization from Brazil's ANVISA to initiate the... 
Via Benzinga
2 Popular Robinhood Stocks I Wouldn't Buy With Free Money
Not every stock on the popular trading app is worth owning. 
Via The Motley Fool
Why Dynavax, Novavax, and Inovio Stocks Sank This Week
Investors appeared to be rattled by the U.S. government's decision to move forward with booster doses of mRNA vaccines. 
Via The Motley Fool
Exposures COVID-19
Unusual Options Activity Insight: Inovio Pharmaceuticals
On Wednesday, shares of Inovio Pharmaceuticals (NASDAQ:INO) saw unusual options activity. After the option alert, the stock price moved down to $8.29. Sentiment: BULLISH Option... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.